Anna Paruzynski

发表

Personalized RNA mutanome vaccines mobilize poly-specific therapeutic immunity against cancer

J. Utikal, Ö. Türeci, U. Şahin, 2017, Nature.

Genome-wide high-throughput integrome analyses by nrLAM-PCR and next-generation sequencing

Stephan Wolf, Wei Wang, Richard Gabriel, 2010, Nature Protocols.

Insertion sites in engrafted cells cluster within a limited repertoire of genomic areas after gammaretroviral vector gene therapy.

C. von Kalle, A. Fischer, Claudia Cattoglio, 2011, Molecular therapy : the journal of the American Society of Gene Therapy.

The fetal mouse is a sensitive genotoxicity model that exposes lentiviral-associated mutagenesis resulting in liver oncogenesis.

Alaine T. Ruthe, Xuegong Zhang, C. von Kalle, 2013, Molecular therapy : the journal of the American Society of Gene Therapy.

Gene therapy for Wiskott-Aldrich syndrome-long - Term efficacy and genotoxicity (Science Translational Medicine)

D. Steinemann, A. Schambach, W. Al-Herz, 2014 .

Cell Cycle Status of CD34+ Hemopoietic Stem Cells Determines Lentiviral Integration in Actively Transcribed and Development-related Genes.

C. von Kalle, I. Kasampalidis, N. Anagnou, 2015, Molecular therapy : the journal of the American Society of Gene Therapy.

Gene therapy for Wiskott-Aldrich Syndrome—Long-term reconstitution and clinical benefits, but increased risk for leukemogenesis

C. von Kalle, C. Klein, Manfred Schmidt, 2014, Rare diseases.

Analysis of the clonal repertoire of gene-corrected cells in gene therapy.

H. Glimm, Manfred Schmidt, C. Kalle, 2012, Methods in enzymology.

Mapping Active Gene-Regulatory Regions in Human Repopulating Long-Term HSCs.

T. Holland-Letz, C. von Kalle, C. Klein, 2018, Cell stem cell.

High-throughput monitoring of integration site clonality in preclinical and clinical gene therapy studies

C. von Kalle, H. Glimm, F. Wenz, 2015, Molecular therapy. Methods & clinical development.

Gene Therapy for Wiskott-Aldrich Syndrome—Long-Term Efficacy and Genotoxicity

Michael Rothe, Christof von Kalle, Raffaele Fronza, 2014, Science Translational Medicine.

Bioinformatic clonality analysis of next-generation sequencing-derived viral vector integration sites.

Christof von Kalle, Richard Gabriel, Hanno Glimm, 2012, Human gene therapy methods.

Retroviral gene therapy for X-linked chronic granulomatous disease: results from phase I/II trial.

C. von Kalle, Manfred Schmidt, C. Bartholomae, 2008, Molecular therapy : the journal of the American Society of Gene Therapy.

Comprehensive genomic access to vector integration in clinical gene therapy

Luca Biasco, Alessandro Aiuti, Richard Gabriel, 2009, Nature Medicine.

Next-generation sequencing of cancer consensus genes in lymphoma

C. von Kalle, A. Jauch, H. Glimm, 2013, Leukemia & lymphoma.

The balance between the intronic miR-342 and its host gene Evl determines hematopoietic cell fate decision

C. von Kalle, C. Klein, H. Glimm, 2021, Leukemia.

Targeted resequencing for analysis of clonal composition of recurrent gene mutations in chronic lymphocytic leukaemia

A. Jauch, A. Ho, H. Glimm, 2013, British journal of haematology.

High-resolution analysis of the human T-cell receptor repertoire

Christof von Kalle, Raffaele Fronza, Hanno Glimm, 2015, Nature Communications.

Lentiviral vector integration profiles differ in rodent postmitotic tissues.

Rafael J. Yáñez-Muñoz, C. von Kalle, B. Korn, 2011, Molecular therapy : the journal of the American Society of Gene Therapy.

Efficacy of Gene Therapy for Wiskott-Aldrich-Syndrome

W. Al-Herz, C. Klein, A. Schwarzer, 2011 .

Immunological and metabolic correction after lentiviral vector mediated haematopoietic stem cell gene therapy for ADA deficiency

K. Cornetta, D. Kohn, A. Thrasher, 2014 .

Successful Combination of Sequential Gene Therapy and Rescue Allo-HSCT in Two Children with X-CGD - Importance of Timing.

J. Tchinda, A. Jauch, M. Grez, 2015, Current gene therapy.